Share Prices & Company Research

Stockbroking

AstraZeneca

Current Price 6089.00p Bid 6087.00p Ask 6089.00p Change 1.26%
Last Updated: 26/05/2019 01:10. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Financial Highlights Year Ended 31/12/2018

Turnover
£22,090.00m
Operating Profit
£3,387.00m
Dividend Yield
3.58
Dividend Per Share
215.20
Dividend Cover
0.79
P/E Ratio
35.37

Key Personnel

Pascal Claude Roland Soriot
Chief Executive Officer
Marc Pierre Jean Dunoyer
Chief Financial Officer
Leif Valdemar Johansson
Non-Executive Chairman
Tony Shu Kam Mok
Non-Executive Director
Marcus Wallenberg
Non-Executive Director
Rudolph Harold Peter Markham
Non-Executive Director
Prof Sabera Nazneen Rahman
Non-Executive Director
Sherilyn Dawn McCoy
Non-Executive Director
Deborah DiSanzo
Non-Executive Director
Graham Andrew Chipchase
Non-Executive Director
Philip Arthur John Broadley
Non-Executive Director
Prof Geneviève Bernadette Berger
Non-Executive Director

Stock Details

EPIC
AZN
ISIN
GB0009895292
Shares in Issue
1,311,759,192
Market cap
£78,876.08m

Analyst Views (12)

Strong Buy
 
41.67%
Buy
 
8.33%
Hold
 
25.00%
Sell
 
8.33%
Strong Sell
 
16.67%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
6089.00p
Bid Price
6087.00p
Ask Price
6089.00p
Volume
1866196
Change Today
76.00p
% Change Today
1.26%
Open
6023.00p
Previous Close
6089.00p
Intraday High
6103.00p
Intraday Low
5981.00p
52 Week High
6540.00p
52 Week Low
5110.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

AstraZeneca Intra-day Chart

AstraZeneca News

News in this section is provided by AJ Bell

Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLC 24 May 2019 | 09:10 Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC 24 May 2019 | 09:00 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 10 May 2019 | 08:10 Director Deals - AstraZeneca PLC (AZN) 08 May 2019 | 17:00 AstraZeneca, Daiichi Sankyo breast cancer treatment meets primary goal 08 May 2019 | 08:24 UK stocks open 0.2% lower after new Trump tariff threat 07 May 2019 | 08:48 AstraZeneca's leukaemia treatment meets primary goal 07 May 2019 | 07:51 AstraZeneca oral treatment for type-2 diabetes gets regulatory nod in US 03 May 2019 | 08:05 Director Deals - AstraZeneca PLC (AZN) 02 May 2019 | 16:25 Director Deals - AstraZeneca PLC (AZN) 02 May 2019 | 16:20 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 02 May 2019 | 10:50 Director Deals - AstraZeneca PLC (AZN) 01 May 2019 | 15:00 Director Deals - AstraZeneca PLC (AZN) 01 May 2019 | 15:00 Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLC 30 Apr 2019 | 10:30 FTSE back in the black by the close 29 Apr 2019 | 16:46 FTSE's progress stalls as markets await Google-parent Alphabet's earnings 29 Apr 2019 | 12:10 UK stocks nudge higher following positive US, China data 29 Apr 2019 | 09:02 AtraZeneca's ovarian cancer treatment receives positive opinion from European regulators 29 Apr 2019 | 07:47 AstraZeneca more than doubles profits in Q1 as newer cancer drugs boost growth 26 Apr 2019 | 07:33 AstraZeneca, MSD advanced breast cancer treatment gets EU regulatory nod 10 Apr 2019 | 07:14 Broker Forecast - Liberum Capital issues a broker note on AstraZeneca PLC 05 Apr 2019 | 08:50 Director Deals - AstraZeneca PLC (AZN) 03 Apr 2019 | 11:25 Director Deals - AstraZeneca PLC (AZN) 03 Apr 2019 | 11:25 Broker Forecast - HSBC issues a broker note on AstraZeneca PLC 02 Apr 2019 | 11:20 Broker Forecast - UBS issues a broker note on AstraZeneca PLC 02 Apr 2019 | 09:50 Broker Forecast - Barclays Capital issues a broker note on AstraZeneca PLC 01 Apr 2019 | 11:00 AstraZeneca, MSD neurofibromatosis type 1 drug gets breakthrough therapy designation in US 01 Apr 2019 | 07:31 FTSE takes advantage of fall in sterling after May's Brexit deal defeated again 29 Mar 2019 | 16:42 FTSE higher as optimism over China-US trade talks builds 29 Mar 2019 | 12:00 UK stocks open 0.5% higher as May readies Brexit deal for vote 29 Mar 2019 | 08:54

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
7,421.0
7,615.0
Intangible Assets & Goodwill
33,666.0
38,013.0
Investments & Other Non-Current Assets
3,973.0
4,576.0
Total Non-Current Assets
45,060.0
50,204.0
Inventory
2,890.0
3,035.0
Trade & Receivables
5,574.0
5,009.0
Cash & Receivables
4,831.0
3,324.0
Other Current Assets & Assets Held for Resale
2,296.0
1,782.0
Total Assets
60,651.0
63,354.0

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
16,292.0
16,383.0
Long Term Liabilities
30,315.0
30,329.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
46,607.0
46,712.0

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
14,044.0
16,642.0

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
317.0
317.0
Minority Interests
1,576.0
1,682.0
Retained Earnings
5,683.0
8,221.0
Share Premium Account
4,427.0
4,393.0
Other Equity
2,041.0
2,029.0
Total Equity
14,044.0
16,642.0

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
2,618.0
3,578.0
Cashflow Before Financing
3,581.0
1,250.0
Increase / Decrease in Cash
1,537.0
-1,686.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
22,090.0
22,465.0
Cost of Sales
4,936.0
4,318.0
Gross Profit
17,154.0
18,147.0
Operating Profit
3,387.0
3,677.0
Pre-Tax Profit
1,993.0
2,227.0
Profit / Loss for the Year
2,050.0
2,868.0

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H2 Dividend
28 Feb 2019
27 Mar 2019
H1 Dividend
09 Aug 2018
10 Sep 2018
H2 Dividend
15 Feb 2018
19 Mar 2018
H1 Dividend
10 Aug 2017
11 Sep 2017
H2 Dividend
16 Feb 2017
20 Mar 2017
H1 Dividend
11 Aug 2016
12 Sep 2016
H2 Dividend
18 Feb 2016
21 Mar 2016
H1 Dividend
13 Aug 2015
14 Sep 2015
H2 Dividend
19 Feb 2015
23 Mar 2015
H1 Dividend
13 Aug 2014
15 Sep 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.